Influence of coenzyme A-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6171-6177

  Trimboli, Anthony J ^a   Waite, B Moseley ^a   Atsumi, Gen Ichi ^a   Fonteh, Alfred N ^a   Namen, Andrew M ^a   Clay, Carl E ^a   Kute, Tim E ^a   High, Kevin P ^a   Willingham, Mark C ^a   Chilton, Floyd H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ARACHIDONIC ACID; COENZYME A; GLUTATHIONE PEROXIDASE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; SB 98625; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACYLTRANSFERASES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ARACHIDONIC ACID; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; HUMANS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0033572353     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Goetzl, E. J., An, S., and Smith, W. L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J., 9: 1051-1058, 1995.
2. Sinclair, H. M. Essential fatty acids - an historical perspective. Biochem. Soc. Trans., 18: 756-761, 1990.
3. Petroni, A., Blasevich, M., Papini, N., La Spada, P., and Galli, C. Changes in arachidonic acid levels and formation in lipid synthesis in the human neuroblastoma SK-N-BE during retinoic acid induced differentiation. J. Neurochem., 67: 549-546, 1996.
4. Bringmann, A., Skatchkov, S. N., Bierdermann, B., Faude, F., and Reichenbach, A. Alterations of potassium channel activity in retinal Muller glial cells induced by arachidonic acid. Neuroscience, 86: 1291-1306, 1998.
5. Reese, E. A., Wu, Y. K., Wiznitzer, A., Homko, C., Yao, J., Borenstein, M., and Sloskey, G. Dietary polyunsaturated fatty acid prevents malformations in offspring of diabetic rats. Am. J. Obstet. Gynecol., 175: 818-823, 1996.
6. Metzger, K., Angres, G., Maier, H., and Lehmann, W. D. Lipoxygenase products in human saliva: patients with oral cancer compared to controls. Free Radical Biol. Med., 18: 185-194, 1995.
7. 2 stimulates the growth of human pancreatic cancer cell line. FEBS Lett., 373: 85-87, 1995.
8. Tripathi, S. C., Vosseller, K. A., and McCormick, D. L. Arachidonic acid metabolism and cell proliferation in rat mammary carcinoma cells treated with indomethacin. Biochim. Biophys. Acta. 1316: 5-7, 1996.
9. 2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J. Biol. Chem., 272: 30504-30511, 1997.
10. 2 has a role in proliferation but not in differentiation of HL-60 cells. Biochim. Biophys. Acta, 1355: 270-280, 1997.
11. Jayadev, S., Linardic, C. M., and Hannun, Y. A. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J. Biol. Chem., 269: 5757-5763, 1994.
12. Korystov, Y. N., Dobrovinskaya, O. R., Shaposhnikova, V. V., and Eidus, L. K. Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation. FEBS Lett., 388: 238-241, 1996.
13. Seegers, J. C. de Kock, M., Lottering, M. L., Grobler, C. J., van Papendorp, D. H., Shou, Y., Habbersett, R., and Lehnert, B. E. Effects of γ-linolenic acid and arachidonic acid on cell cycle progression and apoptosis induction in normal and transformed cells. Prostaglandins Leukotrienes Essent. Fatty Acids, 56: 271-280, 1997.
14. Koller, M., Wachtler, P., David, A., Muhr, G., and Konig, W. Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes. Inflammation, 21: 463-474, 1997.
15. Williams, J. R., Leaver, H. A., Miller, E. P., Whittle, I. R., and Gregor, A. Apoptosis in human primary brain tumors: actions of arachidonic acid. Prostaglandins Leukotrienes Essent. Fatty Acids, 58: 193-200, 1998.
16. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
17. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
18. Subbaramaiah, K., Zakim, D., Weksler, B. B., and Dannenberg, A. J. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. Exp. Biol. Med., 216: 201-210, 1997.
19. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121: 241-246, 1994.
20. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X. J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
21. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
22. Smith, W., Garavito, R., and DeWitt, D. L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem., 271: 33157-33160, 1996.
23. Vanderveen, E. E., Grekin, R. C., Swanson, N. A., and Kragballe, K. Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. Arch. Dermatol., 122: 407-412, 1986.
24. Wu, K. K. Cyclooxygenase-2 induction: molecular mechanism and pathophysiologic roles. J. Investig. Med., 128: 242-245, 1996.
25. Tsuji, S., Kawano, S., Sawaoka, H., Takei, Y., Kobayashi, I., Nagano, K., Fusamoto, H., and Kamada, T. Evidence for involvement of cyclooxygenase-2 in the proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukotrienes Essent. Fatty Acids, 55: 179-183, 1996.
26. Tsujii, M., Kawano, S., and DuBois, R. N. Cyclooxygenase-2 expression in human colon cancer increase metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 3336-3340, 1997.
27. 2. Adv. Exp. Med. Biol., 407: 163-170, 1997.
28. Liu, X. H., and Rose, D. P. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res., 56: 5125-5127, 1996.
29. Hwang, D., Scollard, D., Byrne, J., and Levine, E. Expression of cyclooxygenase-1 and -2 in human breast cancer. J. Natl. Cancer Inst., 90: 455-460, 1998.
30. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
31. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms. Am. J. Physiol., 270(3.1): 393-400, 1996.
32. 1 delay in cells overexpressing proslaglandin endoperoxidase synthase-2. Cancer Res., 56: 733-737, 1996.
33. Watson, A. J. Chemopreventative effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by Cox-1 and Cox-2. Histol. Histopathol., 13: 591-597, 1998.
34. Majima, M., Isono, M., Ikeda, K., Hayashi, I., Hatanaka, K., Harada, Y., Katsumata, O., Yamashina, S., and Katori, M. Significant roles of inducible cyclooxygenase (Cox)-2 in angiogenesis in rat sponge implants. Jpn. J. Pharmacol., 75: 105-114, 1997.
35. Chakraborty, I., Das, S. K., Wang, J., and Dey, S. K. Developmental expression of cyclooxygenase-1 and cyclooxygenase-2 genes in the peri-implanted mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J. Mol. Endocrinol., 16: 107-122, 1996.
36. 2 in human colon cancer cells. Cancer Res., 58: 362-366, 1998.
37. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
38. Hara, A., Yoshimi, N., Niwa, M., Ino, N., and Mori, H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. J. Cancer Res., 88: 600-604, 1997.
39. Sheng, G. G., Shao, J., Sheng, H., Hooten, E. B., Isakson, P. C., Morrow, J. O., Coffey, R. J., Jr., DuBois, R. N., and Beauchamp, R. D. A selective cyclooxygenase-2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gasteroterology, 113: 1883-1891, 1997.
40. Liu, X. H., Yao, S., Kirschenbaum, A., and Levine, A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58: 4245-4249, 1998.
41. Castonguay, A., Rioux, N., Dupemon, C., and Jalbert, G. Inhibition of lung tumori-genesis by NSAIDs: a working hypothesis. Exp. Lung Res., 24: 605-615, 1998.
42. Chan, T. A., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA, 95: 681-686, 1998.
43. Surette, M. E., Fonteh, A. N., Bernatchez, C., and Chilton F. H. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis (Lond.). 20: 757-763, 1999.
44. Finstad, H. S., Kolset, S. O., Holme, J. A., Wiger, R., Farrants, A. K., Blomhoff, R., and Drevon, C. A. Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. Blood, 84: 3799-3809, 1994.
45. Chilton, F. H., Fonteh, A. N., Surette, M. E., Triggiani, M., and Winkler, J. D. Control of arachidonate levels within inflammatory cells. Biochim. Biophys. Acta, 1299: 1-15, 1996.
46. Pulkkinen, J. O., Elomaa, L., Joensuu, H., Martikainen, P., Servomaa, K., and Grenman, P. Paclitaxel-induced apoptotic changes followed by time-lapse video microscopy in cell lines established from head and neck cancer. J. Cancer Res. Clin. Oncol., 122: 214-218, 1996.
47. Collins, J. A., Schandl, C. A., Young, K. K., Vesley, J., and Willingham, M. C. Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem., 45: 923-934, 1997.
48. Clay, C. E., Namen, A. M., Willingham, M. C., Atsumi, G., High, K. P., Kute, T. E., Trimboli, A. J., Fonteh, A. N., Dawson, P. A., and Chilton, F. H. Influence of CoA-independent transacylase and cyclooxygenase inhibitors on the proliferation of breast cancer cells. Carcinogenesis (Lond.), 20(10): 1905-1911, 1999.
49. Bligh, E. G., and Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37: 911-920, 1959.
50. Salari, H., Braquet, P., and Borgeat, P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755c on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukotrienes Essent. Fatty Acids, 13: 53-60, 1984.
51. Chen, Q., Galleano, M., and Cederhaum, A. I. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P450 2EI. J. Biol. Chem., 272: 14532-14541, 1997.
52. Doroshow, J. H. Glutathione peroxidase and oxidative stress. Toxicol. Lett. (Amst.), 83: 395-398, 1995.
53. Triggiani, M., Oriente, A., de Crescenzo, G., Rossi, G., and Marone, G. Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. Int. Arch. Allergy Appl. Immunol., 107: 261-263, 1995.
54. Triggiani, M., Oriente, A., Seeds, M. C., Bass, D., Marone, G., and Chilton, F. H. Migration of human-inflammatory cells into the lung results in remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med., 182: 1181-1190, 1995.